Faye Sharpley

Natural History, Quality of Life, and Outcome in Cardiac Transthyretin Amyloidosis

Thirusha Lane, Marianna Fontana, Ana Martinez–Naharro et al. · Circulation · 2019 · 515 citations · Full text

Medicine, Cardiology, Internal Medicine +14

A prospective observational study of 915 patients with systemic AL amyloidosis treated with upfront bortezomib

Richa Manwani, Oliver Cohen, Faye Sharpley et al. · Blood · 2019 · 192 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +8

Wolbachia Lipoprotein Stimulates Innate and Adaptive Immunity through Toll-like Receptors 2 and 6 to Induce Disease Manifestations of Filariasis

Joseph D. Turner, RJ Langley, Kelly L. Johnston et al. · Journal of Biological Chemistry · 2009 · 140 citations · Full text

Life Sciences, Immunology, Infectious Diseases +15

Analysis of the <i>TTR</i> gene in the investigation of amyloidosis: A 25-year single UK center experience

Dorota Rowczenio, Candida Cristina Quarta, Marianna Fontana et al. · Human Mutation · 2018 · 50 citations

Life Sciences, Genetics, Molecular Genetics +11

Carfilzomib is an effective upfront treatment in AL amyloidosis patients with peripheral and autonomic neuropathy

Richa Manwani, Shameem Mahmood, Sajitha Sachchithanantham et al. · British Journal of Haematology · 2019 · 40 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +9